CD33 and acute myeloid leukemia: The expression of CD13, CD34, CD117, and CD33 on extracellular vesicles isolated from plasma of AML patients may indicate the presence of active leukemic cells.(23) Thus, in clinical practice, flow cytometry assays may incorporate the search for extracellular vesicles as biomarkers of disease activity.